Imperva Inc (IMPV) Rating Lowered to Market Perform at Wells Fargo & Company
Wells Fargo & Company lowered shares of Imperva Inc (NYSE:IMPV) from an outperform rating to a market perform rating in a research report sent to investors on Monday morning, The Fly reports.
A number of other brokerages have also weighed in on IMPV. Stifel Nicolaus reaffirmed a hold rating and issued a $47.00 target price on shares of Imperva in a research note on Friday, July 14th. Stephens reaffirmed an overweight rating and issued a $61.00 target price (up from $53.00) on shares of Imperva in a research note on Thursday, July 13th. BidaskClub lowered shares of Imperva from a buy rating to a hold rating in a research note on Tuesday, July 25th. ValuEngine lowered shares of Imperva from a hold rating to a sell rating in a research note on Tuesday, July 11th. Finally, Monness Crespi & Hardt upped their target price on shares of Imperva from $55.00 to $57.00 and gave the stock a buy rating in a research note on Friday, July 28th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have given a buy rating to the company. The stock has an average rating of Hold and an average target price of $52.34.
Imperva (IMPV) traded up 0.11% during mid-day trading on Monday, hitting $43.55. The stock had a trading volume of 13,720 shares. The company has a 50-day moving average price of $44.05 and a 200 day moving average price of $45.81. Imperva has a 1-year low of $34.40 and a 1-year high of $52.40. The company’s market cap is $1.47 billion.
Imperva (NYSE:IMPV) last announced its quarterly earnings results on Thursday, July 27th. The software maker reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.05 by ($0.15). Imperva had a negative net margin of 4.69% and a negative return on equity of 5.00%. The firm had revenue of $74.44 million during the quarter, compared to analyst estimates of $74.30 million. During the same period last year, the firm earned ($0.23) EPS. Imperva’s quarterly revenue was up 28.6% on a year-over-year basis. Equities research analysts forecast that Imperva will post $0.81 EPS for the current fiscal year.
In other Imperva news, Director Anthony J. Bettencourt sold 99,598 shares of the stock in a transaction that occurred on Thursday, August 24th. The shares were sold at an average price of $43.59, for a total transaction of $4,341,476.82. Following the transaction, the director now owns 99,598 shares in the company, valued at approximately $4,341,476.82. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 2.20% of the company’s stock.
Large investors have recently made changes to their positions in the business. Capital Fund Management S.A. grew its position in shares of Imperva by 85.6% during the 2nd quarter. Capital Fund Management S.A. now owns 113,951 shares of the software maker’s stock worth $5,453,000 after purchasing an additional 52,559 shares in the last quarter. Wells Fargo & Company MN grew its position in shares of Imperva by 86.5% during the 2nd quarter. Wells Fargo & Company MN now owns 191,212 shares of the software maker’s stock worth $9,149,000 after purchasing an additional 88,701 shares in the last quarter. Bank of Nova Scotia acquired a new position in shares of Imperva during the 1st quarter worth approximately $7,184,000. Eagle Asset Management Inc. grew its position in shares of Imperva by 17.7% during the 2nd quarter. Eagle Asset Management Inc. now owns 1,279,848 shares of the software maker’s stock worth $61,240,000 after purchasing an additional 192,625 shares in the last quarter. Finally, Weiss Multi Strategy Advisers LLC grew its position in shares of Imperva by 127.3% during the 1st quarter. Weiss Multi Strategy Advisers LLC now owns 25,000 shares of the software maker’s stock worth $1,026,000 after purchasing an additional 14,000 shares in the last quarter. Hedge funds and other institutional investors own 92.72% of the company’s stock.
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with MarketBeat.com's FREE daily email newsletter.